Prince, H. M., Gautam, A., & Kim, Y. H. (2018). Brentuximab vedotin: Targeting CD30 as standard in CTCL. Oncotarget.
Chicago Style CitationPrince, H. Miles, Ashish Gautam, i Youn H. Kim. "Brentuximab Vedotin: Targeting CD30 As Standard in CTCL." Oncotarget 2018.
Cita MLAPrince, H. Miles, Ashish Gautam, i Youn H. Kim. "Brentuximab Vedotin: Targeting CD30 As Standard in CTCL." Oncotarget 2018.
Atenció: Aquestes cites poden no estar 100% correctes.